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Objective:  As ABCG1  plays  a  role  in  cholesterol  efﬂux,  macrophage  ABCG1  expression  has  been suggested
to  protect  against  atherosclerosis.  However,  we  and  others  observed  varying  effects  of ABCG1  deﬁciency
on  atherosclerotic  lesion  size.  The  objective  of  this  study  was  to deﬁne  the effect of  ABCG1  deﬁciency
during  atherosclerotic  lesion  progression  in  LDL  receptor  knockout  (LDLr−/−) mice.
Methods and  results:  ABCG1−/−/LDLr−/− and  ABCG1+/+/LDLr−/− littermates  were  fed  a Western-type  diet
for  10  and  12  weeks  in  order  to study  the  effect  of ABCG1  deﬁciency  in  the  exponential  phase  of
atherosclerotic  lesion  formation.  At  10  weeks  of  diet  feeding,  a signiﬁcant  1.5-fold  increase  in  early
atherosclerotic  lesion  size  (130 ± 12  × 103m2)  was  observed  in  ABCG1−/−/LDLr−/− mice  compared  to
ABCG1+/+/LDLr−/− mice  (88  ±  11  ×  103m2;  p  < 0.05).  Interestingly,  in  more  advanced  lesions,  induced  by
12  weeks  of  WTD  feeding,  ABCG1−/−/LDLr−/− mice  showed  a signiﬁcant  1.7-fold  decrease  in atheroscle-
rotic  lesion  size  (160  ±  20 ×  103m2 vs  273  ± 19 × 103m2 in  control  mice;  p  <  0.01),  indicating  that  in
the  ABCG1−/−/LDLr−/− mice  progression  of lesion  formation  is  retarded  as  compared  to ABCG1+/+/LDLr−/−
mice.  In  addition,  correlation  analysis  performed  on  7 independent  published  studies  and  the  current
study  conﬁrmed  that  ABCG1  is  atheroprotective  in  early  lesions,  while  the  development  of  advanced
lesions  is stimulated.
Conclusions:  It  appears  that  the  effect  of  ABCG1  deﬁciency  on  lesion  development  in  LDLr−/− mice
depends  on  the stage  of  atherogenesis,  whereby  the  absence  of  ABCG1  leads  to  increased  lesions  at
sizes  < 167  × 103m2 while  in  more  advanced  stages  of atherosclerosis  enhanced  apoptosis  and/or  com-
pensatory  mechanisms  lead to  retarded  lesion  progression.. Introduction
Reverse cholesterol transport (RCT), deﬁned as the transport
f excess cholesterol from peripheral tissues back to the liver for
iliary excretion, plays an important protective role in the develop-
ent of atherosclerosis [1,2]. Previously, the ATP-binding cassette
ABC) transporter A1 has been reported to play an important
ole in the prevention of atherosclerosis by facilitating choles-
erol and phospholipid efﬂux from macrophages to lipid-poor or
ipid-free apolipoprotein AI (apoAI) [3–6]. Similar to ABCA1, ABCG1
as been implicated in macrophage lipid homeostasis by actively
fﬂuxing cellular cholesterol to mature HDL [7,8]. As cholesterol
fﬂux from macrophages is an important protective mechanism
o prevent excessive cellular lipid accumulation, macrophage
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ABCG1 expression was  expected to protect against atherosclero-
sis. However, independent groups have shown that ABCG1 might
be pro-atherogenic as well as anti-atherogenic. Previously, we
reported that both total body and macrophage ABCG1 deﬁciency
led either to a signiﬁcantly increased susceptibility to atheroscle-
rotic lesion development [9,10] or to no change in lesion size
[11,12]. In contrast, the group of Edwards et al. [13,14] and Tall et al.
[15] reported decreased atherosclerosis in LDL receptor knock-
out (LDLr−/−) mice transplanted with ABCG1−/− bone marrow
cells, which was  explained by accelerated apoptosis of ABCG1−/−
macrophages or compensatory upregulation of ABCA1 expression
and apoE secretion in macrophages lacking ABCG1. Thus, the role
of macrophage ABCG1 in the development of atherosclerosis still
remains uncertain.
The  aim of this study was to assess the effect of ABCG1 deﬁ-
ciency on different stages of atherosclerotic lesion development
Open access under the Elsevier OA license.and especially during the exponential phase of lesion formation
in order to unravel the mechanism by which ABCG1 deﬁciency
affects atherogenesis. Upon atherogenic diet feeding, total body
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BCG1−/− mice develop only modest atherosclerotic lesions,
herefore, we generated ABCG1/LDLr double knockout
ABCG1−/−/LDLr−/−) mice to perform this lesion stage dependent
tudy.
. Materials and methods
For detailed methodology, please refer to the data supplement.
ABCG1+/− mice, obtained from Deltagen Inc., San Carlos,
A, were cross-bred with single LDLr−/− mice to generate
BCG1−/−/LDLr−/− mice on a C57Bl/6 background.
To induce atherosclerosis development, the mice were fed
estern-type diet (WTD), containing 15% (w/w) cocoa butter
nd 0.25% (w/w) cholesterol (Diet W,  Ab Diets, Woerden, The
etherlands) for 10 and 12 weeks after which the mice were euth-
nized and atherosclerotic lesion development was  quantiﬁed in
il red O-stained cryosections. Furthermore, bone marrow cells
ere isolated from ABCG1+/+/LDLr−/− and ABCG1−/−/LDLr−/− and
ifferentiated into bone marrow-derived macrophages to evaluate
acrophage cholesterol efﬂux.
. Results
.1. Effect of ABCG1 deﬁciency on serum lipid levels and lipid
omeostasis in tissues
On regular chow diet, containing 4.3% fat and no added choles-
erol, no signiﬁcant difference in total serum cholesterol levels
ere observed between ABCG1+/+/LDLr−/− and ABCG1−/−/LDLr−/−
ice (Table 1). Fractionation of serum lipoproteins, however,
howed a moderate shift of HDL cholesterol to the LDL and
LDL fraction in ABCG1−/−/LDLr−/− mice (HDL: 75 ± 4 com-
ared to 90 ± 3 mg/dL for ABCG1+/+/LDLr−/− mice, p < 0.05; VLDL:
6 ± 3 compared to 19 ± 3 mg/dL, p < 0.001; and LDL: 123 ± 5
ompared to 108 ± 4 mg/dL for ABCG1+/+/LDLr−/− mice, p < 0.05)
Table 1 and Fig. 1A). To induce atherosclerotic lesion develop-
ent, ABCG1−/−/LDLr−/− and control mice were fed a WTD  for 10
nd 12 weeks, which induced approximately a 5-fold increase in
erum cholesterol concentrations in both ABCG1+/+/LDLr−/− and
BCG1−/−/LDLr−/− mice. Both after 10 weeks and 12 weeks on
he WTD, total serum cholesterol levels did not differ between the
roups. Lipoprotein proﬁles of mice fed the WTD  for 10 and 12
eeks were essentially identical. Therefore, the representative 12
eeks WTD  proﬁle of ABCG1−/−/LDLr−/− and control mice on WTD
s shown in Fig. 1A. A moderate increase in VLDL (∼25%) and LDL
∼23%) cholesterol levels was observed in ABCG1−/−/LDLr−/− mice
ompared to control animals, which only reached signiﬁcance for
DL after 12 weeks WTD  feeding (p < 0.01) (Table 1). This increase
n VLDL and LDL was associated with a moderate non-signiﬁcant
ecrease in HDL (∼16%) levels in ABCG1−/−/LDLr−/−. Furthermore,
uring the course of the experiment, the weight gain curve did
ot show signiﬁcant differences between ABCG1−/−/LDLr−/− and
BCG1+/+/LDLr−/− mice both after 10 or 12 weeks on WTD  (data
ot shown).
ABCG1 deﬁciency has been shown to coincide with increased
ecretion of apoE by macrophages and elevated serum apoE lev-
ls [15]. Immunoblotting for apoE was performed to analyze the
ssociation of ABCG1 deﬁciency with serum apoE levels of the
DLr−/− mice fed WTD  for 10 and 12 weeks. No signiﬁcant effect of
BCG1 deﬁciency was observed on serum apoE levels between the
BCG1−/−/LDLr−/− and ABCG1+/+/LDLr−/− mice fed WTD  (Fig. 1B).
n addition, ABCG1 deﬁciency in macrophages has been shown to be
orrelated with an induction of ABCA1 expression [15]. However,
mmunohistochemical staining of aortic root cryosections showed
o apparent increase in ABCA1 expression in macrophages locatedsis 221 (2012) 41– 47
in atherosclerotic lesions of ABCG1−/−/LDLr−/− mice, either after 10
or 12 weeks WTD  feeding (data not shown).
Abnormal lung morphology was observed in ABCG1−/−/LDLr−/−
mice compared with control mice. Both after 10 and 12 weeks
of diet feeding, ABCG1 deﬁciency resulted in accumulation of
large amounts of lipids in the subpleural regions of the lungs
(Supplemental Fig. IA). In addition, spleens of ABCG1−/−/LDLr−/−
showed lipid accumulation in the red pulp regions, while no accu-
mulation was  observed in spleens of control mice (Supplemental
Fig. IB).
3.2. Effect of ABCG1 disruption on atherosclerotic lesion
formation
To deﬁne the role of ABCG1 in the exponential phase of athero-
genesis, atherosclerotic lesion development was  analyzed in the
aortic root of ABCG1+/+/LDLr−/− and ABCG1−/−/LDLr−/− mice after
10 and 12 weeks of WTD  feeding. Representative photomicro-
graphs of the aortic root of control mice and mice deﬁcient for
ABCG1 are shown in Fig. 2A. After 10 weeks WTD  feeding, a signif-
icant 1.5-fold increase in atherosclerotic lesion size was observed
in the aortic root of ABCG1−/−/LDLr−/− mice (130 ± 12 × 103m2
[n = 8] compared to 88 ± 11 ×103m2 [n = 7] for ABCG1+/+/LDLr−/−
mice; p < 0.05). In vitro studies using bone marrow-derived
macrophages of ABCG1+/+/LDLr−/− and ABCG1−/−/LDLr−/− mice
showed that disruption of ABCG1 results in a 15% decrease in
cholesterol efﬂux to HDL (p < 0.001), whereas the cholesterol efﬂux
to ApoAI was unaffected (Fig. 2B). Additional 2 weeks of WTD
feeding resulted in rapid progression of atherosclerotic lesion
development in control mice (3.1-fold) (Fig. 2C). Interestingly,
atherogenesis in the ABCG1-deﬁcient mice appeared to be atten-
uated from 10 till 12 weeks and only a 1.2-fold increase in lesion
size is noticed over this period. As a result, ABCG1-deﬁcient mice
showed a 1.7-fold smaller atherosclerotic lesions as compared to
control mice after 12 weeks WTD  feeding (160 ± 20 × 103m2
[n = 8] compared to 273 ± 19 × 103m2 [n = 9]; p < 0.01, respec-
tively) (Fig. 2A).
Disruption of ABCG1 in LDLr−/− mice also affected the
composition of atherosclerotic lesions. Immunostaining for
macrophages showed less staining in atherosclerotic lesions
of ABCG1−/−/LDLr−/− mice fed WTD  for 10 weeks (65 ± 2% of
atherosclerotic area compared with 81 ± 4% in control mice;
p < 0.01) (Fig. 3A). The lower macrophage content, coincided with
an almost signiﬁcantly larger percentual necrotic core area after
10 weeks on WTD  (22 ± 5% of atherosclerotic area compared
with 8 ± 3% in control mice; p = 0.06). Additional 2 weeks of
WTD  feeding resulted in an increase in absolute macrophage area
and necrotic core area (Fig. 3A). However, no signiﬁcant differ-
ences could be observed between lesions of ABCG1+/+/LDLr−/− and
ABCG1−/−/LDLr−/− mice. Furthermore, Masson Trichrome-staining
showed no signiﬁcant differences in collagen accumulation in the
atherosclerotic plaques between the ABCG1-deﬁcient mice and
control mice after 10 weeks and 12 weeks of WTD  feeding (data
not shown).
As in vitro studies have recently demonstrated that macrophage
ABCG1 deﬁciency is associated with increased susceptibility to apo-
ptosis in response to the altered cellular lipid homeostasis [13],
we examined the apoptotic macrophage content of the lesions by
TUNEL staining. Lesions of ABCG1-deﬁcient mice fed the WTD  for
10 weeks showed no differences in TUNEL-positive macrophages
compared with lesions of control mice (Fig. 3B). After 12 weeks of
WTD  feeding, a 2.5-fold increase in TUNEL-positive macrophages
was observed in lesions of ABCG1−/−/LDLr−/− mice compared
with ABCG1+/+/LDLr−/− animals (p < 0.05, n = 7–8). The decrease in
atherosclerotic lesion size observed in ABCG1−/−/LDLr−/− mice fed
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Table  1
Serum lipid levels in ABCG1−/−/LDLr−/− and control mice on chow and WTD.
Mice Time (weeks) Diet Free cholesterol (mg/dL) Total cholesterol (mg/dL) VLDL-C (mg/dL) LDL-C (mg/dL) HDL-C (mg/dL)
ABCG1+/+/LDLr−/− 0 Chow 96 ± 4 230 ± 12 19 ± 3 108 ± 4 90 ± 3
10 WTD 289 ±  32 1030 ± 36 361 ± 82 369 ± 42 58 ± 4
12 WTD 289 ± 16 1010 ± 82 441 ± 53 374 ± 24 65 ± 6
ABCG1−/−/LDLr−/− 0 Chow 91 ± 4 233 ± 9 36 ± 3*** 123 ± 5* 75 ± 4*
10 WTD  292 ± 23 1206 ± 107 492 ± 81 451 ± 33 58 ± 6
12  WTD  332 ± 20 1047 ± 111 536 ± 57 467 ± 19** 54 ± 5
Data represent the means ± SEM of 8 mice.
Abbreviations:  WTD, Western-type diet; VLDL, very-low-density lipoprotein; LDL, low-density lipoprotein; HDL, high-density lipoprotein; C, cholesterol.
* Statistical signiﬁcance of p < 0.05 compared with ABCG1+/+/LDLr−/− mice.
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A** Statistical signiﬁcance p < 0.01 compared with ABCG1+/+/LDLr−/− mice.
*** Statistical signiﬁcance p < 0.001 compared with ABCG1+/+/LDLr−/− mice.
TD  for 12 weeks, might therefore be a result of increased sus-
eptibility to apoptosis of ABCG1-deﬁcient macrophages inside the
esions.
Overall, these ﬁndings indicate that the effect of ABCG1 deﬁ-
iency on atherosclerotic lesion development depends on the
tage of atherogenesis. ABCG1 expression protects against early
therosclerotic lesion development, by facilitating cholesterol
fﬂux from macrophages to HDL. In the more advanced lesions,
owever, accumulation of cholesterol due to impaired cholesterol
fﬂux from ABCG1-deﬁcient macrophages, eventually, will lead to
ncreased macrophage apoptosis and a reduced further progression
f atherogenesis.
. DiscussionSeveral pathways are involved in the efﬂux of cholesterol from
acrophages, including aqueous diffusion, SR-BI mediated choles-
erol efﬂux, efﬂux dependent on macrophage apoE secretion, and
ig. 1. The effect of ABCG1 deﬁciency on serum cholesterol distribution and apoE levels
hile  feeding a regular chow diet and after 12 weeks on WTD. Sera from individual mice 
epresent VLDL, fractions 6–14 represent LDL, and fractions 15–20 represent HDL. The dis
BCG1−/−/LDLr−/− () mice is shown. Values represent the mean ± SEM of 8 mice per g
BCG1−/−/LDLr−/− mice after 12 weeks of WTD  feeding.active cholesterol efﬂux mediated by ABCA1 [16–18].  Also ABCG1
has been implicated in cellular lipid homeostasis by its prop-
erty to actively efﬂux cholesterol to mature HDL [8,19].  Studies
using genetically engineered mice have established the physiolog-
ical importance of ABCG1. Targeted disruption of ABCG1 in mice
resulted in age-related progressive pulmonary lipidosis when fed a
regular chow diet [20–22].  In addition, overexpression of ABCG1
protected against diet-induced lipid deposition within multiple
tissues [8].  These ﬁndings imply a critical role for ABCG1 in main-
taining normal lipid metabolism in the lung, thereby preventing
inﬂammatory responses triggered by massive cholesterol and/or
cholesterol metabolite accumulation.
Although the critical role of ABCG1 in lung lipid homeosta-
sis is clearly established, contradictory ﬁndings on the role of
macrophage ABCG1 in the development of atherosclerosis have
been reported by different groups/laboratories [9–15,23–25].
Transgenic mice overexpressing human ABCG1 showed either
no effect [24] or increased atherosclerosis [25]. In contrast,
 in LDLr−/− mice. (A) Blood samples were drawn after an overnight fasting period
were loaded onto a Superose 6 column, and fractions were collected. Fractions 2–5
tribution of cholesterol over the different lipoproteins in ABCG1+/+/LDLr−/− () and
roup. (B) A representative immunoblot of apoE in serum of ABCG1+/+/LDLr−/− and
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Fig. 2. The effect of ABCG1 deﬁciency on atherosclerotic lesion formation and cholesterol efﬂux in LDLr−/− mice. (A) Atherosclerotic lesion formation was determined in the
aortic  root at the level of the tricuspid valves of ABCG1+/+/LDLr−/− and ABCG1−/−/LDLr−/− mice fed a WTD  for 10 and 12 weeks (separated by the dotted line). Mean lesion
area  of each individual mouse is shown. The horizontal dotted lines represent the means of each group of 7–9 mice. Representative photomicrographs of oil red O-stained
lesions  are shown (magniﬁcation 50×). (B) Cholesterol efﬂux to HDL is impaired in ABCG1-deﬁcient macrophages. ApoA-I (10 g/mL) and HDL (50 g/mL) induced cellular
cholesterol efﬂux from 3H-cholesterol-labeled bone marrow-derived macrophages of ABCG1+/+/LDLr−/− and ABCG1−/−/LDLr−/− mice. Basal efﬂux to BSA (in the absence of
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pdded  acceptors) has been subtracted from the data shown. Values represent the me
BCG1−/−/LDLr−/− mice from 10 to 12 weeks WTD  feeding is shown. Values represen
s  compared to ABCG1+/+/LDLr−/− controls.
esterterp et al. [26] recently reported an atheroprotective role of
ascular ABCG1, which is likely related to its role in the preserva-
ion of endothelial NO synthase activity. Furthermore, independent
tudies, using ABCG1-deﬁcient mice or LDLr−/− mice transplanted
ith bone marrow cells of ABCG1-deﬁcient mice, have shown that
acrophage ABCG1 might be proatherogenic [9,10,12] as well as
ntiatherogenic [13–15].  In the present study, we show that ABCG1
eletion in LDLr−/− mice can both induce and attenuate atheroscle-
otic lesion development. ABCG1 deﬁciency led to a signiﬁcant 48%
ncrease in atherosclerotic lesion size after only 10 weeks Western-
ype diet feeding, while a signiﬁcant 32% decrease in lesion size was
bserved after 12 weeks WTD  feeding. These data imply that the
ffect of ABCG1 deﬁciency on atherosclerotic lesion development
n LDLr−/− mice depends on the stage of atherogenesis.
The reduced atherosclerosis in LDLr−/− mice transplanted with
BCG1−/− bone marrow was suggested to be a result of com-
ensatory induction of apoE secretion and ABCA1 expression inEM of 4 animals. (C) Progression of atherosclerotic lesions of ABCG1 /LDLr and
ean ± SEM of 7–9 mice. Statistically signiﬁcant difference *p < 0.05 and ***p  < 0.001
ABCG1-deﬁcient macrophages [15]. In this study, however, both
at 10 weeks and 12 weeks of WTD  feeding, ABCG1−/−/LDLr−/−
mice showed no compensatory increase in serum apoE lev-
els, although ABCG1−/−/LDLr−/− mice did exhibit a decrease in
atherosclerotic lesion development at 12 weeks of WTD  feed-
ing. These ﬁndings are in agreement with our previous studies
showing that apoE mRNA and protein expressions were not
affected upon deletion of ABCG1 [10,12]. In addition, no appar-
ent increase in ABCA1 expression was  observed in ABCG1-deﬁcient
macrophages in atherosclerotic lesions of LDLr−/−. Furthermore,
accelerated apoptosis was  proposed as a mechanism for the
reduced atherosclerosis susceptibility of LDLr−/− mice lacking
ABCG1 in macrophages [13,14]. In agreement, in the present study,
the more advanced atherosclerotic lesions of ABCG1−/−/LDLr−/−
mice fed WTD  for 12 weeks were decreased in size and showed
a signiﬁcant increase in TUNEL-positive macrophages as com-
pared to control mice. Macrophage apoptosis is an important
I. Meurs et al. / Atherosclerosis 221 (2012) 41– 47 45
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Fig. 3. Disruption of ABCG1 affects the composition of atherosclerotic lesions. (A) Quantiﬁcation of lesion macrophages and necrotic core in ABCG1+/+/LDLr−/− (open bars)
and  ABCG1−/−/LDLr−/− (closed bars) after 10 and 12 weeks of WTD  feeding are depicted. The macrophage lesion area and necrotic core area were histochemically quantiﬁed
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acrophages after 10 and 12 weeks of WTD  feeding using the TUNEL staining. Sta
ontrols.
eature of atherosclerotic plaque development and occurs dur-
ng all stages of atherosclerosis with increasing frequencies as the
laque develops [27]. Research directed at understanding the func-
ional consequences of macrophage death in atherosclerosis has
evealed opposing roles for apoptosis in atherosclerotic plaque pro-
ression. Under normal physiologic conditions, apoptotic cells are
apidly cleared by phagocytes, a process called efferocytosis. In
arly atherosclerotic lesions, macrophage apoptosis, followed by
fferocytosis limits lesion cellularity and suppresses plaque pro-
ression [28,29].  In advanced lesions, efferocytosis is defective and
nder these conditions macrophage apoptosis thus promotes the
evelopment of the necrotic core [30,31].
We  show that lesions of ABCG1−/−/LDLr−/− mice fed WTD  for
0 weeks exhibited an increase in necrotic core in the absence
f an increase in TUNEL-positive macrophages. In addition, in
therosclerotic lesions induced by 12 weeks WTD  feeding, ABCG1
eﬁciency did not affect necrotic core size, despite a signiﬁ-
ant increase in macrophage apoptosis. These ﬁndings suggest
hat analyses of macrophage apoptosis are a snapshot and that
here may  be additional determinants of the lesional necrotic
ore area. Necrosis can be either secondary to apoptosis (sec-
ndary necrosis) or a primary process [32]. In particular, necrotic
ores are formed by multiple processes, including accumulation of
oth intracellular and extracellular lipid [33,34]. Several stud-
es have reported that ABCG1−/− macrophages are indeed more
usceptible to oxLDL-induced apoptosis as compared to ABCG1-
xpressing cells [13,14,35].  Efﬂux of 7-ketocholesterol, the main
xysterol present in oxLDL, is completely dependent on expres-
ion of ABCG1 and not on the expression of ABCA1 [35]. Therefore,
BCG1-deﬁcient macrophages show increased accumulation of(left) and expressed as absolute area (m ) (right). (B) Quantiﬁcation of apoptotic
lly signiﬁcant difference *p < 0.05 and **p < 0.01 as compared to ABCG1+/+/LDLr−/−
7-ketocholesterol upon oxLDL loading, which is cytotoxic to the cell
and induces accelerated apoptosis [14,35] indicating that ABCG1 is
essential for the prevention of oxLDL-induced apoptosis.
Our ﬁndings suggest that in addition to accelerated apoptosis,
ABCG1 deﬁciency also leads to increased necrotic core formation.
Under normal physiological conditions, necrotic core formation
becomes more prominent in advanced lesions. In absence of
ABCG1, however, necrotic core formation is already evident in early
atherosclerotic lesions.
The current study indicates that the effect of ABCG1 deﬁciency
on atherosclerotic lesion size depends on the stage of lesion
development. To investigate the differential effects found on
atherosclerosis susceptibility upon disruption of ABCG1, cor-
relation analysis was performed on published studies of the
independent groups, the current study, and one other unpublished
study of our group. Experimental details of these studies are repre-
sented in Table 2. Although different diets and protocols were used
in the individual studies, a high correlation (R = 0.92) can be found
when the fold increase/decrease in atherosclerotic lesion size of
ABCG1−/− mice compared to ABCG1+/+ mice is plotted against the
atherosclerotic lesion size of ABCG1+/+ mice (Fig. 4). Based on this
clear correlation, we  propose that the effect of ABCG1 deﬁciency
on lesion development depends on the stage of atherogenesis.
In early atherosclerotic lesions (lesions < 167 × 103m2), ABCG1
deﬁciency causes an increase in atherosclerotic lesion develop-
ment (ratio > 1.0), most likely as a direct result of the impaired
cholesterol efﬂux to HDL in ABCG1-deﬁcient macrophages.
This indicates that ABCG1 expression is protective in early
atherosclerotic lesion development. Interestingly, at atheroscle-
rotic lesion sizes above 167 × 103m2, the role of ABCG1 in
46 I. Meurs et al. / Atherosclerosis 221 (2012) 41– 47
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Fig. 4. Relative increase/decrease in atherosclerotic lesion size of ABCG1−/−/LDLr−/−
mice compared to ABCG1+/+/LDLr−/− mice plotted to atherosclerotic lesion size
of ABCG1+/+/LDLr−/− mice. Data from bone marrow transplantation studies in
LDLr−/− mice and total body studies by different groups, the present study, and
unpublished studies are included (experimental details represented in Table 2). In
early atherosclerotic lesions (lesions < 167 × 103 m2), ABCG1 deﬁciency causes an
increase in atherosclerotic lesion development (ratio > 1.0), while at atherosclerotic
lesion sizes above 167 × 103 m2, enhanced apoptosis and/or compensatory mecha-
nisms lead to retarded lesion progression. The numbers given in the graph represent
the  reference numbers of the different studies.
atherogenesis switches from anti-atherosclerotic to pro-
atherosclerotic. In more advanced lesions, the persistent impaired
cholesterol efﬂux from ABCG1-deﬁcient macrophages is likely to
induce accumulation of (oxy)sterols, which leads to enhanced apo-
ptosis/compensatory mechanisms and, subsequently, decreased
atherosclerotic lesion size (ratio < 1.0). Previously, we [10] have
also reported a highly signiﬁcant correlation when the fold
increase/decrease in atherosclerotic lesion size of ABCG1−/− as
compared with ABCG1+/+ is plotted against total serum cholesterol
whereby at about 900 mg/dL serum cholesterol a switch from
ABCG1’s protective function to lesion formation was noticed.
When recent published studies of the independent groups,
the current study, and two  other unpublished studies of our
group are included, again a high correlation between the fold
increase/decrease in atherosclerotic lesion size and total serum
cholesterol is observed with a switch at 1000 mg/dL serum
cholesterol from an atheroprotective function of ABCG1 to a
proatherogenic function (p = 0.0075; R = 0.73). Therefore, under
normal physiological levels of cholesterol, the role of ABCG1 in
atherogenesis is likely to be protective. Furthermore, since higher
serum cholesterol levels are associated with a more rapid devel-
opment of atherosclerotic lesions, this correlation is probably also
a direct effect of the stage of atherosclerotic lesion development.
In conclusion, our results indicate that the effect of ABCG1
on lesion development depends on the stage atherogenesis,
whereby the absence of ABCG1 leads to increased lesions at
sizes < 167 × 103m2 while in more advanced stages of atheroscle-
rosis enhanced apoptosis and/or compensatory mechanisms lead to
retarded lesion progression.
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